Lentiviral Vector Production and Gene Delivery Systems

Lentiviral vectors are derived from lentiviruses such as HIV-1 and serve as potent gene delivery vehicles due to their capacity to integrate stably into the host genome and transduce both dividing and non-dividing cells. Production encompasses upstream processes including the design of transfer plasmids encoding the gene of interest, selection or engineering of packaging cell lines to express viral structural and enzymatic proteins, and optimisation of transfection or stable producer cell systems. Downstream operations involve clarification, concentration and purification via ultracentrifugation, tangential flow filtration and affinity chromatography to achieve high titre, purity and safety. Recent advances include the integration of process analytical technology for real-time monitoring and adaptive control, the development of novel chromatographic ligands and membrane adsorbers that enhance yield and impurity clearance, and the generation of robust stable cell lines that enable continuous, scalable manufacture. Together, these innovations underpin the translation of lentiviral vectors into clinical gene and cell therapies, vaccine design and functional genomics, highlighting their global significance.

Research from Nature Portfolio

Recent studies have demonstrated the application of refractometry-based process analytical technology combined with metabolic modelling to monitor HEK293T cultures in real time, revealing how pH and oxygen availability interplay to influence cellular metabolism and guiding adaptive pH control strategies that boost metabolic activity without compromising vector production. Complementing this, the construction of stable packaging cell lines via site-specific recombinase systems has yielded producer clones capable of continuous lentiviral vector generation at titres exceeding ten to the power of six transducing units per millilitre, offering enhanced reproducibility and scalability over transient transfection. In parallel, a novel stable producer line utilising a mutated viral protease has delivered constitutive vector output above one million transducing units per millilitre per day, overcoming cytotoxic limitations of viral components and streamlining development timelines.

Lentiviral Vector Production and Gene Delivery Systems publication trend

The graph below shows the total number of articles in lentiviral vector production and gene delivery systems across all publications each year (not limited to Nature Index journals).

Technical terms

Lentiviral vector: A replication-deficient viral particle derived from a lentivirus, employed to deliver genetic material into target cells.

Pseudotyping: The replacement of the native viral envelope protein with an alternative glycoprotein to modify cell tropism and vector stability.

Transducing unit (TU): A quantification of functional viral particles capable of effecting gene transfer per unit volume.

Affinity chromatography: A purification method that isolates vectors by specific binding to immobilised ligands.

Stable packaging cell line: A genetically engineered cell line that constitutively expresses viral structural and regulatory proteins for vector assembly.

Process analytical technology (PAT): Real-time monitoring tools used to assess and control bioprocess parameters, ensuring consistent product quality.

References

1. Lentiviral Vector Bioprocessing. Viruses (2021).
2. Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges. Pharmaceutics (2020).
3. Machine learning and metabolic modelling assisted implementation of a novel process analytical technology in cell and gene therapy manufacturing. Scientific Reports (2023).
4. Construction of stable packaging cell lines for clinical lentiviral vector production. Scientific Reports (2015).
5. LentiPro26: novel stable cell lines for constitutive lentiviral vector production. Scientific Reports (2018).
6. Developing a process of lentivirus purification from recombinant fluids using peptide affinity ligands. Bioengineering & Translational Medicine (2025).
7. Implementation of Novel Affinity Ligand for Lentiviral Vector Purification. International Journal of Molecular Sciences (2023).
8. Engineering an Autonucleolytic Mammalian Suspension Host Cell Line to Reduce DNA Impurity Levels in Serum-Free Lentiviral Process Streams. ACS Synthetic Biology (2024).